Stock Research: Encompass

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Encompass

NYSE:EHC US29261A1007
62
  • Value
    52
  • Growth
    59
  • Safety
    Safety
    39
  • Combined
    35
  • Sentiment
    87
  • 360° View
    360° View
    62
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Encompass Health Corporation operates inpatient rehabilitation hospitals, providing compassionate rehabilitative care for patients recovering from major injuries or illnesses. It specializes in comprehensive patient care for conditions like strokes, hip fractures, and neurological conditions, and treats debilitating effects of COVID-19. It operates in 38 states and Puerto Rico, with concentrations in Florida and Texas. In the last fiscal year, the company had a market cap of $10832 million, profits of $5134 million, revenue of $5373 million, and 23564 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 62 (better than 62% compared with alternatives), overall professional sentiment and financial characteristics for the stock Encompass are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Encompass. The consolidated Growth Rank has a good rank of 59, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 59% of competitors in the same industry. The consolidated Safety Rank at 52 means that the company has a financing structure that is safer than 52% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 87, which means that professional investors are more optimistic about the stock than for 87% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 39, meaning that the share price of Encompass is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 61% of alternative stocks in the same industry. ...read more

more
Index
Dividends USA
D.J. US Health Care
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 35 56 94
Growth
59 74 85 37
Safety
Safety
52 20 28 23
Sentiment
87 100 98 77
360° View
360° View
62 57 91 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
95 93 93 73
Opinions Change
80 86 50 50
Pro Holdings
n/a 93 88 77
Market Pulse
40 60 72 40
Sentiment
87 100 98 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 35 56 94
Growth
59 74 85 37
Safety Safety
52 20 28 23
Combined
35 36 65 46
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
30 34 45 86
Price vs. Earnings (P/E)
25 13 38 64
Price vs. Book (P/B)
17 25 28 68
Dividend Yield
75 77 79 82
Value
39 35 56 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
66 64 70 50
Profit Growth
65 51 70 77
Capital Growth
40 55 84 9
Stock Returns
63 77 57 43
Growth
59 74 85 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
40 31 30 30
Refinancing
31 17 35 30
Liquidity
66 56 45 48
Safety Safety
52 20 28 23

Similar Stocks

Discover high‑ranked alternatives to Encompass and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.